Oxygen saturation targets in preterm infants and outcomes at 18-24 months: A systematic review

Pediatrics

Volumn 139, Issue 1, 2017, Pages

  Manja, Veena ^a,b   Saugstad, Ola D ^c   Lakshminrusimha, Satyan ^d  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

CHILD DEATH; DEVELOPMENTAL DISORDER; HUMAN; INCIDENCE; INFANT MORTALITY; NEURODEVELOPMENTAL IMPAIRMENT; OXYGEN SATURATION; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; VISUAL IMPAIRMENT; BLOOD; COMPARATIVE STUDY; DOSE RESPONSE; INFANT; MENTAL DISEASE; MORTALITY; NEWBORN; OUTCOME ASSESSMENT; OXIMETRY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SURVIVAL RATE;

CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFANT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; NEURODEVELOPMENTAL DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); OXIMETRY; OXYGEN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL RATE;

EID: 85009143080     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-1609     Document Type: Review

References (47)

1. Vento M, Saugstad OD. Oxygen as a therapeutic agent in neonatology: A comprehensive approach. Semin Fetal Neonatal Med. 2010;15(4): 185-189
2. Silverman WA. Oxygen therapy and retrolental fibroplasia. Am J Public Health Nations Health. 1968;58(11):2009-2011
3. Robertson AF. Reflections on errors in neonatology: I. The "Hands-Off" years, 1920 to 1950. J Perinatol. 2003;23(1):48-55
4. Bolton DP, Cross KW. Further observations on cost of preventing retrolental fibroplasia. Lancet. 1974;1(7855):445-448
5. American Academy of Pediatrics, American College of Obstetricians and Gynecologists, March of Dimes Birth Research Foundation. Guidelines for Perinatal Care. Elk Grove Village, IL: American Academy of Pediatrics; 2007
6. Greenspan JS, Goldsmith JP. Oxygen therapy in preterm infants: hitting the target. Pediatrics. 2006;118(4):1740-1741
7. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349(10):959-967
8. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W; NeOProM Collaborative Group. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr. 2011;11(1):6
9. Carlo WA, Finer NN, Walsh MC, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362(21):1959-1969
10. Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al; BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368(22):2094-2104
11. Schmidt B, Whyte RK, Asztalos EV, et al; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: A randomized clinical trial. JAMA. 2013;309(20): 2111-2120
12. Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed. 2011;96(6):F429-F433
13. Saugstad OD, Aune D. Optimal oxygenation of extremely low birth weight infants: A meta-analysis and systematic review of the oxygen saturation target studies. Neonatology. 2014;105(1):55-63
14. Manja V, Lakshminrusimha S, Cook DJ. Oxygen saturation target range for extremely preterm infants: A systematic review and meta-analysis. JAMA Pediatr. 2015;169(4):332-340
15. Tarnow-Mordi W, Stenson B, Kirby A, et al; BOOST-II Australia and United Kingdom Collaborative Groups. Outcomes of two trials of oxygensaturation targets in preterm infants. N Engl J Med. 2016;374(8):749-760
16. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407-415
17. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. J Clin Epidemiol. 2011;64(12):1294-1302
18. Guyatt GH, Oxman AD, Kunz R, et al; GRADE Working Group. GRADE guidelines: 8. Rating the quality of evidence-indirectness. J Clin Epidemiol. 2011;64(12):1303-1310
19. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. J Clin Epidemiol. 2011;64(12):1283-1293
20. Guyatt GH, Oxman AD, Montori V, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. J Clin Epidemiol. 2011;64(12):1277-1282
21. Borenstein M, Hedges LV, Higgins JPT, et al. Introduction to Meta-Analysis. Hoboken, NJ: Wiley; 2011
22. Vaucher YE, Peralta-Carcelen M, Finer NN, et al; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367(26):2495-2504
23. Darlow BA, Marschner SL, Donoghoe M, et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165(1):30-35.e2
24. Polin RA, Bateman D. Oxygen-saturation targets in preterm infants. N Engl J Med. 2013;368(22):2141-2142
25. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C.composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003;289(19):2554-2559
26. Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome-2016 update. Neonatology. 2016;111(2):107-125
27. Manley BJ, Kuschel CA, Elder JE, Doyle LW, Davis PG. Higher rates of retinopathy of prematurity after increasing oxygen saturation targets for very preterm infants: experience in a single center. J Pediatr. 2016;168:242-244
28. Cummings JJ, Lakshminrusimha S, Polin RA. Oxygen-saturation targets in preterm infants. N Engl J Med. 2016;375(2):186-187
29. Stenson BJ. Oxygen saturation targets for extremely preterm infants after the NeOProM Trials. Neonatology. 2016;109(4):352-358
30. Tarnow-Mordi W, Stenson B, Kirby A. Oxygen-saturation targets in preterm infants. N Engl J Med. 2016;375(2):187-188
31. Lakshminrusimha S, Manja V, Mathew B, Suresh GK. Oxygen targeting in preterm infants: A physiological interpretation. J Perinatol. 2015;35(1):8-15
32. Sola A, Golombek SG, Montes Bueno MT, et al. Safe oxygen saturation targeting and monitoring in preterm infants: can we avoid hypoxia and hyperoxia? Acta Paediatr. 2014;103(10):1009-1018
33. Schmidt B, Roberts RS, Whyte RK, et al. Impact of study oximeter masking algorithm on titration of oxygen therapy in the Canadian oxygen trial. J Pediatr. 2014;165(4):666-671.e2
34. Lal M, Tin W, Sinha S. Automated control of inspired oxygen in ventilated preterm infants: crossover physiological study. Acta Paediatr. 2015;104(11):1084-1089
35. van Kaam AH, Hummler HD, Wilinska M, et al. Automated versus manual oxygen control with different saturation targets and modes of respiratory support in preterm infants. J Pediatr. 2015;167(3):545-50.e1-2
36. Schmidt B, Whyte RK, Shah PS, et al; Canadian Oxygen Trial (COT) Group. Effects of targeting higher or lower oxygen saturations in centers with more versus less seperation between median saturations. J Pediatr. 2016;178:288-291.e2
37. Walsh MC, Di Fiore JM, Martin RJ, Gantz M, Carlo WA, Finer N. Association of oxygen target and growth status with increased mortality in small for gestational age infants: further analysis of the Surfactant, Positive Pressure and Pulse Oximetry Randomized Trial. JAMA Pediatr. 2016;170(3):292-294
38. Lakshminrusimha S, Manja V, Steinhorn RH. Interaction of target oxygen saturation, bronchopulmonary dysplasia, and pulmonary hypertension in small for gestational age preterm neonates. JAMA Pediatr. 2016;170(8):807-808
39. Bhandari V, Gruen JR. What is the basis for a genetic approach in neonatal disorders? Semin Perinatol. 2015;39(8):568-573
40. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics. 2006;118(5):1858-1863
41. Bhandari V, Bizzarro MJ, Shetty A, et al; Neonatal Genetics Study Group. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics. 2006;117(6):1901-1906
42. Ravelli AC, Schaaf JM, Mol BW, et al. Antenatal prediction of neonatal mortality in very premature infants. Eur J Obstet Gynecol Reprod Biol. 2014;176:126-131
43. Quine D, Stenson BJ. Does the monitoring method influence stability of oxygenation in preterm infants? A randomised crossover study of saturation versus transcutaneous monitoring. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):F347-F350
44. Cummings JJ, Polin RA; Committee on Fetus and Newborn. Oxygen targeting in extremely low birth weight infants. Pediatrics. 2016;138(2):e20161576
45. Synnes A, Miller SP. Oxygen therapy for preterm neonates: The elusive optimal target. JAMA Pediatr. 2015;169(4):311-313
46. Hergenhan A, Steurer M, Berger TM. Gestational age-adapted oxygen saturation targeting and outcome of extremely low gestational age neonates (ELGANs). Swiss Med Wkly. 2015;145:w14197
47. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105(2):295-310